Last reviewed · How we verify
Placebo of Gasmotin — Competitive Intelligence Brief
phase 3
Gastroenterology
Small molecule
Live · refreshed every 30 min
Target snapshot
Placebo of Gasmotin (Placebo of Gasmotin) — Daewoong Pharmaceutical Co. LTD.. This is a placebo formulation with no active pharmacological mechanism.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Placebo of Gasmotin TARGET | Placebo of Gasmotin | Daewoong Pharmaceutical Co. LTD. | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Placebo of Gasmotin CI watch — RSS
- Placebo of Gasmotin CI watch — Atom
- Placebo of Gasmotin CI watch — JSON
- Placebo of Gasmotin alone — RSS
Cite this brief
Drug Landscape (2026). Placebo of Gasmotin — Competitive Intelligence Brief. https://druglandscape.com/ci/placebo-of-gasmotin. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab